Interleukin-10 Downregulates Anti-Microbial Peptide Expression in Atopic Dermatitis

This publication has 33 references indexed in Scilit:

• Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003
  Published by Elsevier ,2004
• Atopic dermatitis
  The Lancet, 2003
• Innate antimicrobial peptide protects the skin from invasive bacterial infection
  Nature, 2001
• Cutaneous Injury Induces the Release of Cathelicidin Anti-Microbial Peptides Active Against Group A Streptococcus
  Journal of Investigative Dermatology, 2001
• IL-10: Evolving concepts
  Journal of Allergy and Clinical Immunology, 1998
• IL-10 is a key cytokine in psoriasis. Proof of principle by IL-10 therapy: a new therapeutic approach.
  Journal of Clinical Investigation, 1998
• Granulocyte macrophage colony-stimulating factor is overproduced by keratinocytes in atopic dermatitis. Implications for sustained dendritic cell activation in the skin.
  Journal of Clinical Investigation, 1997
• Differential Cytokine Profiles in Peripheral Blood Lymphocyte Supernatants and Skin Biopsies from Patients with Different Forms of Atopic Dermatitis, Psoriasis and Normal Individuals
  International Archives of Allergy and Immunology, 1994
• Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells.
  The Journal of Experimental Medicine, 1993
• Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes.
  The Journal of Experimental Medicine, 1991